课题基金 / 基金详情

A Real Time Monitoring System for IOP in Glaucoma

A Real Time Monitoring System for IOP in Glaucoma
青光眼眼压实时监测系统
批准号:
6732699
负责人:
Doug J Jackson
金额:
$25.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2005-12-31

项目摘要

项目成果

Doug J Jackson的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供):Assenti随附的NEI / SBIR提案旨在为青光眼导致视神经损伤的患者提供连续、无创的24小时眼内压(IOP)监测。该项目可被视为“预防失明的辅助技术”。眼压升高被认为是青光眼发生和发展的最重要的危险因素。基于几项临床研究,目前青光眼的治疗管理旨在通过将IOP降低至临床水平来阻止疾病进展。 使用医疗、激光或手术治疗可接受的水平。高眼压治疗研究(OHTS)最近已将IOP升高确定为青光眼发作的重要预测因素[9]。晚期青光眼干预研究证明了低IOP对青光眼患者视野恶化的保护作用[10]。即使在NPG中,传统的IOP降低干预也显示出疾病进展显著减少[11,12]。使用青光眼动物模型的实验研究支持了IOP引发因素对于视神经的青光眼变性是重要的临床观察。 来自路易斯维尔大学Speed工程学院和眼科与视觉科学系的合作研究团队沿着与主要行业合作伙伴联合成立了一家名为Assenti LLC的公司。Assenti将构建一个带有机载遥测的集成电路(IC)压力传感器,该传感器将放置在昏迷眼的前房内,以在24小时内连续记录10至40 mm Hg之间的Lop。遥测电路将被开发为向传感器IC提供电力以及从传感器IC接收数据,而不需要电池或电线。提供电力并从IC接收数据的初级线圈将容纳在眼镜架上,眼镜架可由受试者佩戴。可以预见,所有接受治疗的确诊青光眼患者, 已经启动的医疗或手术,将是该设备的候选者。这三个具体目标和潜在的革命性青光眼治疗如下: 1.制作了2个基于压阻和电容设计的超小型MEMS压力传感器。 2.开发用于电力和数据通信的遥测电路。 3.在体外和体内条件下测试MEMS压力传感器和遥测电路。
英文摘要
DESCRIPTION (provided by applicant): Assenti's enclosed NEI / SBIR proposal is intended to provide continuous, non-invasive 24 hour monitoring of Intra-Ocular Pressure (lOP) in patients with optic nerve damage from glaucoma. The project can be viewed as "assistive technology for prevention of blindness". Elevated lOP is thought to be the most important risk factor for the initiation and progression of glaucoma. The current therapeutic management of glaucoma, based on several clinical studies, aims to halt disease progression by reducing lOP to clinically acceptable levels using medical, laser or surgical treatments. The Ocular Hypertension Treatment Study (OHTS) has recently identified elevated lOP as an important predictor for the onset of glaucoma [9]. The Advanced Glaucoma Intervention Study demonstrated a protective role for low lOP in visual field deterioration detected in glaucomatous patients [10]. Even in NPG disease progression has been shown to be markedly reduced by the traditional intervention of lOP reduction [11,12]. Experimental studies using animal models of glaucoma support the clinical observations that lOP initiated factors are important for glaucomatous degeneration of the optic nerve. Collaborative research teams from the University of Louisville's Speed School of Engineering and the Department of Ophthalmology & Visual Sciences along with key industry partners have combined to form a corporation named Assenti LLC. Assenti will construct an integrated circuit (IC) pressure sensor with onboard telemetry that will be placed within the anterior chamber of the glaucomatous eye to record Lop between 10 and 40 mm Hg continuously over 24 hours. The telemetric circuit will be developed to provide power to the sensor IC as well as receive data from the sensor IC without requiring batteries or wires. The primary coil that provides power and receives data from the IC will be housed on spectacle frames, which can be worn by the subject. It is envisioned that all patients with established glaucoma in whom treatment has been initiated, either medical or surgical, would be candidates for the device. The three specific aims and for this potentially revolutionary treatment of glaucoma are as follows: 1. Fabricate 2 ultra-miniature MEMS pressure sensors based on a piezoresistive and capacitance designs. 2. Development of the telemetry circuitry for power and data communication. 3. Test the MEMS pressure sensors and telemetry circuitry under both in vitro and in vivo conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Real Time Monitoring System to Measure IOP in Glaucoma
  • 批准号:
    7225914
  • 项目类别:
  • 资助金额:
    $37.5万
  • 财政年份:
    2003
  • 负责人:
    Doug J Jackson
  • 依托单位:
A Real Time Monitoring System for IOP in Glaucoma
  • 批准号:
    6631101
  • 项目类别:
  • 资助金额:
    $25.07万
  • 财政年份:
    2003
  • 负责人:
    Doug J Jackson
  • 依托单位:
A Real Time Monitoring System to Measure IOP in Glaucoma
  • 批准号:
    7053206
  • 项目类别:
  • 资助金额:
    $37.5万
  • 财政年份:
    2003
  • 负责人:
    Doug J Jackson
  • 依托单位: